Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Pfizer presents new mu-selective opioid receptor ligands and use thereof

Dec. 21, 2000

New 4-arylpiperidine derivatives for the treatment of pruritus

Dec. 21, 2000

Tetralone and thienylcyclohexanone derivatives selectively bind to GABA-A alpha5 subunit

Dec. 21, 2000

Protein farnesyltransferase inhibitors useful for cancer therapy patented by BMS

Dec. 21, 2000

New use claimed by Sanofi-Synthelabo for succinic acid derivatives

Dec. 21, 2000

GABA analogues reported to modulate substance P

Dec. 21, 2000

Vivus granted third PDE inhibitor patent

Dec. 21, 2000

Improved compositions of LHRH or somatostatin analogues described in recent patent

Dec. 20, 2000

More stable salts of thrombin inhibitors prepared at BASF

Dec. 20, 2000

Novel polymers for conjugation with proteins and peptides designed by Enzon

Dec. 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...